Literature DB >> 23749101

Mutations of two transmembrane cysteines of hemagglutinin (HA) from influenza A H3N2 virus affect HA thermal stability and fusion activity.

Shun Xu1, Jianqiang Zhou, Kang Liu, Qiliang Liu, Chunyi Xue, Xiaoming Li, Jing Zheng, Dongyu Luo, Yongchang Cao.   

Abstract

Influenza A H3N2 virus caused 1968 Hong Kong influenza pandemic, and has since been one of the most prevalent seasonal influenza viruses in global populations, representing a credible pandemic candidate in future. Previous studies have established that the hemagglutinin (HA) protein is the predominant antigen and executes receptor binding and membrane fusion. Homologous sequence analysis of all HA subtypes of influenza viruses revealed that two cysteine residues (540 and 544) are uniquely present in the transmembrane domain (TM) of HA proteins from all influenza A H3N2 viruses. However, the functions of these two cysteines have not been fully studied. Here, we generated three mutants (C540S, C544L, and 2C/SL) to investigate the effects of the two TM cysteines on the biological functions of H3 HA. We herein presented evidences that the mutations of one or two of the cysteines did not affect the proper expressions of HA proteins in cells, and more importantly all mutant H3 HAs showed decreased thermal stability but increased fusion activity in comparison with wildtype HA. Our results taken together demonstrated that the two TM cysteines are important for the biological functions of H3 HA proteins.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23749101     DOI: 10.1007/s11262-013-0924-0

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  34 in total

1.  Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin.

Authors:  X Han; J H Bushweller; D S Cafiso; L K Tamm
Journal:  Nat Struct Biol       Date:  2001-08

2.  Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion.

Authors:  G B Melikyan; S Lin; M G Roth; F S Cohen
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

3.  Optimized fixation and immunofluorescence staining methods for Dictyostelium cells.

Authors:  Monica Hagedorn; Eva M Neuhaus; Thierry Soldati
Journal:  Methods Mol Biol       Date:  2006

4.  Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus.

Authors:  Peter Pushko; Thomas Kort; Margret Nathan; Melissa B Pearce; Gale Smith; Terrence M Tumpey
Journal:  Vaccine       Date:  2010-05-12       Impact factor: 3.641

5.  The global circulation of seasonal influenza A (H3N2) viruses.

Authors:  Colin A Russell; Terry C Jones; Ian G Barr; Nancy J Cox; Rebecca J Garten; Vicky Gregory; Ian D Gust; Alan W Hampson; Alan J Hay; Aeron C Hurt; Jan C de Jong; Anne Kelso; Alexander I Klimov; Tsutomu Kageyama; Naomi Komadina; Alan S Lapedes; Yi P Lin; Ana Mosterin; Masatsugu Obuchi; Takato Odagiri; Albert D M E Osterhaus; Guus F Rimmelzwaan; Michael W Shaw; Eugene Skepner; Klaus Stohr; Masato Tashiro; Ron A M Fouchier; Derek J Smith
Journal:  Science       Date:  2008-04-18       Impact factor: 47.728

6.  Structural characterization of an early fusion intermediate of influenza virus hemagglutinin.

Authors:  Rui Xu; Ian A Wilson
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

7.  Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.

Authors:  Rick A Bright; Donald M Carter; Shannon Daniluk; Franklin R Toapanta; Attiya Ahmad; Victor Gavrilov; Mike Massare; Peter Pushko; Nutan Mytle; Thomas Rowe; Gale Smith; Ted M Ross
Journal:  Vaccine       Date:  2007-02-15       Impact factor: 3.641

8.  Membrane perturbation and fusion pore formation in influenza hemagglutinin-mediated membrane fusion. A new model for fusion.

Authors:  P Bonnafous; T Stegmann
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

9.  Intermediates in influenza induced membrane fusion.

Authors:  T Stegmann; J M White; A Helenius
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

10.  Membrane interaction and structure of the transmembrane domain of influenza hemagglutinin and its fusion peptide complex.

Authors:  Ding-Kwo Chang; Shu-Fang Cheng; Eric Aseen B Kantchev; Chi-Hui Lin; Yu-Tsan Liu
Journal:  BMC Biol       Date:  2008-01-15       Impact factor: 7.431

View more
  9 in total

1.  Evidences for the existence of intermolecular disulfide-bonded oligomers in the H3 hemagglutinins expressed in insect cells.

Authors:  Shun Xu; Jianqiang Zhou; Qiliang Liu; Kang Liu; Chunyi Xue; Xiaoming Li; Jing Zheng; Dongyu Luo; Yongchang Cao
Journal:  Virus Genes       Date:  2013-12-03       Impact factor: 2.332

2.  Recombinant influenza A H3N2 viruses with mutations of HA transmembrane cysteines exhibited altered virological characteristics.

Authors:  Jianqiang Zhou; Shun Xu; Jun Ma; Wen Lei; Kang Liu; Qiliang Liu; Yida Ren; Chunyi Xue; Yongchang Cao
Journal:  Virus Genes       Date:  2013-11-23       Impact factor: 2.332

3.  Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency loss.

Authors:  Kathleen M Holtz; Pamela S Robinson; Erin E Matthews; Yoshifumi Hashimoto; Clifton E McPherson; Nikolai Khramtsov; Michael J Reifler; Jamal Meghrous; David G Rhodes; Manon M Cox; Indresh K Srivastava
Journal:  BMC Biotechnol       Date:  2014-12-24       Impact factor: 2.563

4.  Recombinant influenza H9N2 virus with a substitution of H3 hemagglutinin transmembrane domain showed enhanced immunogenicity in mice and chicken.

Authors:  Yun Zhang; Ying Wei; Kang Liu; Mengjiao Huang; Ran Li; Yang Wang; Qiliang Liu; Jing Zheng; Chunyi Xue; Yongchang Cao
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

5.  Disulfide isomerase ERp57 improves the stability and immunogenicity of H3N2 influenza virus hemagglutinin.

Authors:  Jialing Wu; Yang Wang; Ying Wei; Zhichao Xu; Xin Tan; Zhihui Wu; Jing Zheng; George Dacai Liu; Yongchang Cao; Chunyi Xue
Journal:  Virol J       Date:  2020-04-21       Impact factor: 4.099

6.  Identification of a universal antigen epitope of influenza A virus using peptide microarray.

Authors:  Qiuxia Wang; Zhihao Sun; Jingzhi Li; Tao Qin; Hongwei Ma; Sujuan Chen; Daxin Peng; Xiufan Liu
Journal:  BMC Vet Res       Date:  2021-01-07       Impact factor: 2.741

Review 7.  Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus.

Authors:  Yun Zhang; Cong Xu; Hao Zhang; George Dacai Liu; Chunyi Xue; Yongchang Cao
Journal:  Viruses       Date:  2019-04-30       Impact factor: 5.048

8.  H7 virus-like particles assembled by hemagglutinin containing H3N2 transmembrane domain and M1 induce broad homologous and heterologous protection in mice.

Authors:  Jianru Qin; Yun Zhang; Xiaoting Shen; Lang Gong; Ouyang Peng; Yuan Liu; Chunyi Xue; Yongchang Cao
Journal:  Vaccine       Date:  2018-07-07       Impact factor: 3.641

9.  Recombinant influenza H1, H5 and H9 hemagglutinins containing replaced H3 hemagglutinin transmembrane domain showed enhanced heterosubtypic protection in mice.

Authors:  Qiliang Liu; Kang Liu; Chunyi Xue; Jianqiang Zhou; Xiaoming Li; Dongyu Luo; Jing Zheng; Shun Xu; George Dacai Liu; Yongchang Cao
Journal:  Vaccine       Date:  2014-04-03       Impact factor: 3.641

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.